| 1 |
34132894 | Anti-rituximab antibodies in pediatric steroid-dependent nephrotic syndrome. | 2022 Feb |
1 |
| 2 |
34661744 | Circulating plasmablasts in children with steroid-sensitive nephrotic syndrome. | 2022 Feb |
1 |
| 3 |
35240381 | Novel treatment options in rituximab-resistant membranous nephropathy patients. | 2022 Jun |
1 |
| 4 |
33518484 | [Rituximab treatment in pediatric patients with steroid-dependent nephrotic syndrome: a tertiary hospital]. | 2021 Jan 28 |
1 |
| 5 |
33807051 | A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab. | 2021 Mar 23 |
1 |
| 6 |
34544820 | Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial. | 2021 Oct |
1 |
| 7 |
30564879 | Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children. | 2020 Jan |
1 |
| 8 |
32619893 | Rituximab as an effective therapeutic option in refractory Neuro-Behçet syndrome. | 2020 Jun 26 |
1 |
| 9 |
33628202 | Rituximab Induces Complete Remission of Proteinuria in a Patient With Minimal Change Disease and No Detectable B Cells. | 2020 |
1 |
| 10 |
31365055 | Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series. | 2019 Sep 1 |
1 |
| 11 |
31881522 | A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonism. | 2019 Dec 19 |
1 |
| 12 |
29436729 | Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome. | 2018 Jun |
1 |
| 13 |
27789116 | Risks and Benefits of Rituximab in the Treatment of Hashimoto Encephalopathy in Children: Two Case Reports and a Mini Review. | 2017 Jan |
1 |
| 14 |
28314744 | Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol. | 2017 Mar 17 |
1 |
| 15 |
28366912 | Low-dose rituximab as an adjuvant therapy in pemphigus. | 2017 May-Jun |
1 |
| 16 |
28415773 | Effects of CD20+ B-cell infiltration into allografts on kidney transplantation outcomes: a systematic review and meta-analysis. | 2017 Jun 6 |
2 |
| 17 |
28058267 | The Effect of Histological CD20-Positive B Cell Infiltration in Acute Cellular Rejection on Kidney Transplant Allograft Survival. | 2016 |
2 |
| 18 |
24552605 | Diabetes and immune thrombocytopenic purpura: a new association with good response to anti-CD20 therapy. | 2015 Mar |
1 |
| 19 |
24880619 | Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy. | 2015 Feb |
1 |
| 20 |
25594706 | [Rituximab therapy for relapsing IgG4-autoimmune pancreatitis and cholangitis - a case report]. | 2015 Jan |
1 |
| 21 |
25741456 | Rituximab Treatment for Nephrotic Syndrome in Children. | 2015 |
1 |
| 22 |
26087994 | Monoclonal antibodies for renal diseases: current concepts and ongoing treatments. | 2015 |
1 |
| 23 |
22948319 | Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome. | 2013 Jan |
2 |
| 24 |
23144195 | Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years. | 2013 Jun |
1 |
| 25 |
23612383 | Transient effect of anti-CD20 therapy in a child with 22q11.2 deletion syndrome and severe steroid refractory cytopenias: a case report. | 2013 May |
1 |
| 26 |
24348405 | Successful corticosteroid-sparing effect of rituximab in the treatment of refractory idiopathic orbital inflammatory disease. | 2013 |
1 |
| 27 |
22443503 | Novel strategy to treat a case of recurrent lymphocytic hypophysitis using rituximab. | 2012 Jun |
1 |
| 28 |
21471566 | Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis. | 2011 Nov |
1 |
| 29 |
21727772 | Successful treatment of steroid-refractory autoimmune thrombocytopenia associated with Castleman disease with anti-CD-20 antibody (rituximab). | 2011 |
1 |
| 30 |
20393401 | Clinical impacts of CD38+ B cells on acute cellular rejection with CD20+ B cells in renal allograft. | 2010 Jun 27 |
1 |
| 31 |
19460565 | Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report. | 2009 May |
1 |
| 32 |
17899207 | Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible? | 2008 Jan |
1 |
| 33 |
17973121 | Rituximab for refractory focal segmental glomerulosclerosis. | 2008 Mar |
1 |
| 34 |
18547992 | Characterization of intra-graft B cells during renal allograft rejection. | 2008 Sep |
1 |
| 35 |
18580460 | "To B or not to B?" B-cells and graft rejection. | 2008 Jun 27 |
1 |
| 36 |
17264461 | Beneficial effects of rituximab therapy for systemic lupus erythematosus. | 2007 Jan |
1 |
| 37 |
17461736 | New treatments for acute humoral rejection of kidney allografts. | 2007 May |
1 |
| 38 |
17532766 | Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients. | 2007 Jul |
1 |
| 39 |
17823525 | Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab. | 2007 |
1 |
| 40 |
16823816 | Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. | 2006 Aug |
1 |
| 41 |
17198274 | CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. | 2006 Dec 27 |
1 |
| 42 |
15834625 | Treatment of dys-immune neuropathies. | 2005 Apr |
1 |
| 43 |
16095505 | Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. | 2005 Sep |
1 |
| 44 |
12819245 | Rituximab in idiopathic membranous nephropathy: a one-year prospective study. | 2003 Jul |
1 |
| 45 |
12931119 | Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. | 2003 Aug |
1 |
| 46 |
11923690 | Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. | 2002 Mar 27 |
1 |